About the Journal
Indonesian Journal of Endocrinology Metabolism and Diabetes (InaJEMD) is an open accessed online journal and comprehensive peer-reviewed medical journal published by the Indonesian Society of Endocrinology since 2024. Our main mission is to publish and disseminate research results that are relevant to current and future scientific development needs.
InaJEMD is an open accessed online journal. We are welcome authors for original articles, case report, case series, case illustration, review articles, systematic review, and clinical practice. Authors are invited to submit articles that have not been published previously and are not under consideration elsewhere. Preparations of manuscript should follow the author guidelines of InaJEMD.
e-ISSN 3063-1408
ISSN 3048-3271
Distribution : Open Access
Frequency Publish : July and Desember
Published by : Perkumpulan Endokrinologi Indonesia (PERKENI)
Instagram : perkeni_ig
Current Issue
Vol. 2 No. 1 (2025): InaJEMD Vol. 2, No. 1
InaJEMD: Indonesian Journal of Endocrinology, Metabolism, and Diabetes publishes scientific articles on research results and Case Reports in the field of Endocrinology, Metabolism, and diabetes. Vol. 2 No. 1 (July 2025) contains 13 articles, consisting of 2 original research and 11 case reports, written by authors from various medical institutions and hospitals in Indonesia.
Contributors to this edition include the Faculty of medicine, specialist medical education programs, and teaching hospitals such as YARSI University, Brawijaya University, Andalas University, Sebelas Maret University, North Sumatra University, Gadjah Mada University, Dr. Cipto Mangunkusumo, and several other Endocrinology service centers.
Topics raised include thyroid carcinoma cell culture, glycemic control constraints in Type 2 diabetes, parathyroid disorders, detection of insulinoma lesions using PET/CT, primary thyroid lymphoma, gynecomastia and galactorrhea in elderly men, agranulocytosis due to antithyroid drugs, hashitoxycosis, multiple autoimmune syndromes, to pituitary adenomas in patients with severe comorbidities. This edition demonstrates InaJEMD's commitment in presenting clinical studies and research relevant to endocrinology practice in Indonesia.
Published:
01-07-2025
